↓ Skip to main content

Cochrane Database of Systematic Reviews

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children

Overview of attention for article published in Cochrane database of systematic reviews, April 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Citations

dimensions_citation
188 Dimensions

Readers on

mendeley
351 Mendeley
Title
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Published in
Cochrane database of systematic reviews, April 2013
DOI 10.1002/14651858.cd006602.pub4
Pubmed ID
Authors

Tea Andabaka, Jason W Nickerson, Maria Ximena Rojas‐Reyes, Juan David Rueda, Vesna Bacic Vrca, Bruno Barsic

Abstract

Respiratory syncytial virus (RSV) is one of the most important viral pathogens causing acute respiratory infections in children. It results in about 3.4 million hospitalisations annually in children under five. Palivizumab is an anti-RSV monoclonal antibody, administered intramuscularly at a dose of 15 mg/kg once every 30 days. The efficacy and safety of palivizumab has been evaluated in multicentre, randomised controlled trials (RCTs) and a large number of economic evaluations (EEs) have tested its cost-effectiveness.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 351 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 <1%
United Kingdom 2 <1%
France 1 <1%
South Africa 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 343 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 52 15%
Researcher 47 13%
Student > Bachelor 37 11%
Student > Ph. D. Student 37 11%
Student > Postgraduate 28 8%
Other 57 16%
Unknown 93 26%
Readers by discipline Count As %
Medicine and Dentistry 134 38%
Nursing and Health Professions 26 7%
Social Sciences 19 5%
Immunology and Microbiology 13 4%
Agricultural and Biological Sciences 11 3%
Other 41 12%
Unknown 107 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 159. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2024.
All research outputs
#259,489
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#429
of 13,156 outputs
Outputs of similar age
#1,671
of 204,681 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 265 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,681 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 265 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.